Article Details

Curie Therapeutics lines up $75M to tackle radiopharmaceuticals with former Ra Pharma execs

Retrieved on: 2021-12-01 20:49:20

Tags for this article:

Click the tags to see associated articles and topics

Curie Therapeutics lines up $75M to tackle radiopharmaceuticals with former Ra Pharma execs. View article details on hiswai:

Excerpt

Read was CSO and Ricardo was chief technology officer at Ra, which caught UCB's eyes for its phase 3 rival to Alexion's Soliris.

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up